Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tomas Bergvall"'
Publikováno v:
BASE-Bielefeld Academic Search Engine
Drug Safety
Drug Safety
Introduction A large number of studies on systems to detect and sometimes normalize adverse events (AEs) in social media have been published, but evidence of their practical utility is scarce. This raises the question of the transferability of such s
Autor:
Anna Pierini, Ester Garne, Vera Nelen, Anna Materna-Kiryluk, Clara Cavero-Carbonell, Maria Loane, Kari Klungsøyr, Anke Rissmann, Nathalie Lelong, Babak Khoshnood, Joan K Morris, Helen Dolk, Awi Wiesel, Amanda Nevill, Inger Öhman, Tomas Bergvall, Mary O'Mahony, Ingeborg Barišić, Reneé Lutke, David Tucker, Lyubov Yevtushok, Alana Cavadino, Miriam Gatt, Anna Latos-Bielenska, Hanitra Randrianaivo, Olatz Mokoroa, Lovisa Sandberg, Kristina Star, Marie-Claude Addor
Publikováno v:
Drug Safety, 44(7), 765-785. ADIS INT LTD
Drug Safety
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cavadino, A, Sandberg, L, Öhman, I, Bergvall, T, Star, K, Dolk, H, Loane, M, Addor, M C, Barisic, I, Cavero-Carbonell, C, Garne, E, Gatt, M, Khoshnood, B, Klungsøyr, K, Latos-Bielenska, A, Lelong, N, Lutke, R, Materna-Kiryluk, A, Nelen, V, Nevill, A, O’Mahony, M, Mokoroa, O, Pierini, A, Randrianaivo, H, Rissmann, A, Tucker, D, Wiesel, A, Yevtushok, L & Morris, J K 2021, ' Signal Detection in EUROmediCAT : Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference ', Drug Safety, vol. 44, no. 7, pp. 765-785 . https://doi.org/10.1007/s40264-021-01073-z
Drug Safety
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cavadino, A, Sandberg, L, Öhman, I, Bergvall, T, Star, K, Dolk, H, Loane, M, Addor, M C, Barisic, I, Cavero-Carbonell, C, Garne, E, Gatt, M, Khoshnood, B, Klungsøyr, K, Latos-Bielenska, A, Lelong, N, Lutke, R, Materna-Kiryluk, A, Nelen, V, Nevill, A, O’Mahony, M, Mokoroa, O, Pierini, A, Randrianaivo, H, Rissmann, A, Tucker, D, Wiesel, A, Yevtushok, L & Morris, J K 2021, ' Signal Detection in EUROmediCAT : Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference ', Drug Safety, vol. 44, no. 7, pp. 765-785 . https://doi.org/10.1007/s40264-021-01073-z
Introduction\ud Knowledge on the safety of medication use during pregnancy is often sparse. Pregnant women are generally excluded from clinical trials, and there is a dependence on post-marketing surveillance to identify teratogenic medications.\ud \
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86e364d11f5eb4a54c92d34d60923fb
Autor:
G. Niklas Norén, Juergen Dietrich, Johan Ellenius, Victoria Newbould, Gregory Powell, Simon Maskell, Munir Pirmohamed, Nabarun Dasgupta, Sara Gama, John van Stekelenborg, Carrie E. Pierce, Antoni F. Z. Wiśniewski, Ola Caster, David J. Lewis, Phil Tregunno, Alicia Ptaszynska-Neophytou, Sabine Brosch, Tomas Bergvall
Publikováno v:
Drug Safety
BASE-Bielefeld Academic Search Engine
BASE-Bielefeld Academic Search Engine
Over a period of 3 years, the European Union's Innovative Medicines Initiative WEB-RADR project has explored the value of social media (i.e., information exchanged through the internet, typically via online social networks) for identifying adverse ev
Autor:
Daniele Sartori, Birgitta Grundmark, Sara Hult, Sara Hedfors Vidlin, Johan Ellenius, Tomas Bergvall, G. Niklas Norén
Publikováno v:
Drug Safety
Introduction Adverse drug reactions related to drug–drug interactions cause harm to patients. There is a body of research on signal detection for drug interactions in collections of individual case reports, but limited use in regular pharmacovigila
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose vigiRank is a data-driven predictive model for emerging safety signals. In addition to disproportionate reporting patterns, it also accounts for the completeness, recency, and geographic spread of individual case reporting, as well as the ava
Autor:
Pia Caduff-Janosa, Kristina Star, I. Ralph Edwards, Imti Choonara, Lovisa Sandberg, Tomas Bergvall
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose The purpose of this study is to uncover previously unrecognised risks of medicines in paediatric pharmacovigilance reports and thereby advance a safer use of medicines in paediatrics. Methods Individual case safety reports (ICSRs) with ages l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6a6e2e36cf0b1b4ace96fa7fb4d67e
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-390043
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-390043
Publikováno v:
Drug Safety
Individual case safety reports of suspected harm from medicines are fundamental to post-marketing surveillance. Their value is directly proportional to the amount of clinically relevant information they include. To improve the quality of the data, co
Publikováno v:
Drug Safety
Background Individual case safety reports of suspected harm from medicines are fundamental to post-marketing surveillance. Their value is directly proportional to the amount of clinically relevant information they include. To improve the quality of t
Autor:
G. Niklas Norén, Patrick B. Ryan, Martijn J. Schuemie, Tomas Bergvall, Kristina Juhlin, David Madigan
Publikováno v:
Drug Safety, 36, S107-S121. Adis
Observational healthcare data offer the potential to identify adverse drug reactions that may be missed by spontaneous reporting. The self-controlled cohort analysis within the Temporal Pattern Discovery framework compares the observed-to-expected ra
Autor:
G. Niklas Norén, I. Ralph Edwards, Alexander Tropsha, Xiaoling Zang, Yen Low, Tomas Bergvall, Ola Caster, Denis Fourches, Ivan Rusyn
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA
Objective Quantitative Structure-Activity Relationship (QSAR) models can predict adverse drug reactions (ADRs), and thus provide early warnings of potential hazards. Timely identification of potential safety concerns could protect patients and aid ea